Hyperbaric oxygen combined with intravenous edaravone for treatment of acute embolic stroke: a pilot clinical trial. | Canada Hyperbarics Skip to main content
Prospective Study Neurologia medico-chirurgica 2006

Hyperbaric oxygen combined with intravenous edaravone for treatment of acute embolic stroke: a pilot clinical trial.

Imai K, Mori T, Izumoto H, Takabatake N, Kunieda T, Watanabe M — Neurologia medico-chirurgica, 2006

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers prospectively investigated the efficacy of hyperbaric oxygen therapy combined with intravenous edaravone administration in patients with acute embolic stroke, comparing it to conventional treatment.

What They Found

At 90 days, 6 out of 19 patients (31.6%) in the hyperbaric oxygen and edaravone group achieved a favorable outcome, compared to only 1 out of 19 patients (5.3%) in the control group (p < 0.05). However, there was no significant difference in National Institutes of Health Stroke Scale scores between the two groups at 7 days.

Canadian Relevance

This study was conducted in Japan and has no direct Canadian connection.

Study Limitations

Key limitations include the small sample size of this pilot study and its single-center design.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Neurological
Source Pubmed
PubMed ID 16936457
Year Published 2006
Journal Neurologia medico-chirurgica
MeSH Terms Acute Disease; Aged; Antipyrine; Combined Modality Therapy; Edaravone; Emergency Medical Services; Female; Free Radical Scavengers; Humans; Hyperbaric Oxygenation; Intracranial Embolism; Male; Neuroprotective Agents; Pilot Projects; Severity of Illness Index

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology